HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hans-Jürgen Bidmon Selected Research
Hans-Jürgen Bidmon Research Topics
Disease
4
Hepatic Encephalopathy
01/2020 - 01/2009
3
Hyperammonemia
01/2020 - 02/2011
3
Liver Cirrhosis (Hepatic Cirrhosis)
10/2019 - 07/2011
2
Fibrosis (Cirrhosis)
07/2011 - 07/2010
1
Liver Diseases (Liver Disease)
10/2019
1
Liver Failure
10/2019
1
Temporal Lobe Epilepsy
10/2018
1
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017
1
Myocardial Infarction
05/2016
1
Inflammation (Inflammations)
01/2014
1
Carcinogenesis
01/2014
1
Neuroinflammatory Diseases
07/2011
1
Epilepsy (Aura)
08/2010
1
Pneumonia (Pneumonitis)
07/2010
1
Brain Ischemia (Cerebral Ischemia)
10/2004
Drug/Important Bio-Agent (IBA)
4
Messenger RNA (mRNA)
IBA
06/2013 - 07/2010
3
Ammonia
IBA
10/2019 - 02/2011
3
Proteins (Proteins, Gene)
FDA Link
07/2011 - 07/2010
2
Cytokines
IBA
06/2013 - 07/2011
2
Interleukin-6 (Interleukin 6)
IBA
02/2011 - 07/2010
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
02/2011 - 07/2010
2
RNA (Ribonucleic Acid)
IBA
02/2011 - 07/2010
2
Tyrosine (L-Tyrosine)
FDA Link
02/2011 - 07/2010
2
Neurotransmitter Receptors (Neurotransmitter Receptor)
IBA
08/2010 - 01/2009
1
Histamine (Histamine Dihydrochloride)
FDA Link
01/2020
1
Glutamate-Ammonia Ligase (Glutamine Synthetase)
IBA
01/2020
1
A-factor (Streptomyces)
IBA
10/2019
1
Protein Glutamine gamma Glutamyltransferase 2
IBA
10/2019
1
Taurine
FDA Link
10/2019
1
Staphylococcal Protein A (Protein A)
IBA
10/2018
1
N-Ethylmaleimide-Sensitive Proteins (N-Ethylmaleimide-Sensitive Fusion Protein)
IBA
10/2018
1
Vitamins
IBA
01/2017
1
Fluorocarbons
IBA
05/2016
1
Micronutrients
IBA
01/2014
1
Selenium
IBA
01/2014
1
Selenoproteins (Selenoprotein)
IBA
01/2014
1
Chemokines
IBA
07/2011
1
Indomethacin (Indometacin)
FDA Link
Generic
02/2011
1
Pentylenetetrazole (Metrazol)
IBA
08/2010
1
8-hydroxyguanosine
IBA
07/2010
1
Glial Cell Line-Derived Neurotrophic Factor (GDNF)
IBA
10/2004
Therapy/Procedure
1
Therapeutics
01/2020